contact
Committed to transforming
the treatment of severe, chronic
autoimmune diseases.
About us
Technology
Pipeline
Business development
Careers
News & Events
Contact
contact
Menu
Committed to transforming
the treatment of severe, chronic
autoimmune diseases.
About us
Technology
Pipeline
Business development
Careers
News & Events
Contact
News
2021-06-24
Imcyse appoints new Scientific Advisory Board and opens new laboratories for next phase of growth
Read more
2021-06-24
INNODIA is ready for a new phase – clinical trials
Read more
2021-02-17
Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round – Pfizer Joins as Newest Shareholder
Read more
2021-02-03
Imcyse Enters into Research Collaboration and License Agreement for its Imotope™ Technology with Pfizer in Rheumatoid Arthritis
Read more
2021-02-03
Imcyse Announces Start of Phase 1b/2a IMPACT Study in Patients with Recent Onset Type 1 Diabetes
Read more
1
2
3
4
Go Back